Patients who are using GLP-1 drugs need to be sure that theyre continuing to eat nutritious, well-balanced diets
How does BPC-157 compare to TB-500 or NSAIDs for injury recovery
Learn about their differences, research applications, and why they're often combined in laboratory protocols
In some early trials, effects like shorter sleep latency were seen fairly quickly (within hours) after administration
In this multicentre trial (often referred to as the STEP AMY trial, in line with the semaglutide obesity trials naming convention), 706 adults without diabetes and with BMI in the obese range were randomised to receive one of five doses of cagrilintide (0.3, 0.6, 1.2, 2.4, or 4.5 mg weekly), or an active comparator of liraglutide 3.0 mg daily (the then-standard GLP-1 obesity therapy), or placebopubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov
Suppliers making bold medical promises may be operating outside legal boundaries, which raises questions about their overall business practices
